59 results on '"Kruszon-Moran, Deanna"'
Search Results
2. SARS-CoV-2 Serology and Self-Reported Infection Among Adults — National Health and Nutrition Examination Survey, United States, August 2021–May 2022
3. Cytomegalovirus Seroprevalence Among US Children Aged 1 to 5 Years: The National Health and Nutrition Examination Surveys, 2017–March 2020 Pre-Pandemic Dataset
4. Prevalence and Trends in HIV Infection and Testing Among Adults in the United States: The National Health and Nutrition Examination Surveys, 1999–2018
5. Prevalence of Urogenital Mycoplasma genitalium Infection, United States, 2017 to 2018
6. Breastfeeding Duration and Cytomegalovirus Seroprevalence Among US Children Aged 1–5 Years: The National Health and Nutrition Examination Surveys, 2011–2012 and 2017–2018
7. Concurrent Seroprevalence of Antibodies to Toxoplasma gondii and Toxocara Species in the United States, 2011–2014
8. Toxoplasma gondii Infection in the United States, 2011–2014
9. Effect of Breastfeeding and Additional Household Children on Cytomegalovirus Seroprevalence among U.S. Children 1 to 5 Years of Age
10. Viral and parasitic pathogen burden and the association with stroke in a population-based cohort
11. Seroprevalence of Antibodies to Toxocara Species in the United States and Associated Risk Factors, 2011–2014
12. Influence of parity and sexual history on cytomegalovirus seroprevalence among women aged 20-49 years in the USA
13. Trends in Obesity Among Adults in the United States, 2005 to 2014
14. Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
15. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988‐2012
16. Influence of Parity and Sexual History on Cytomegalovirus Seroprevalence Among Women 20–49 Years Old
17. Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
18. Seroprevalence of Cytomegalovirus among Children 1 to 5 Years of Age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012
19. Did CDC's 2006 Revised HIV Testing Recommendations Make a Difference? Evaluation of HIV Testing in the US Household Population, 2003–2010
20. Toxoplasma gondii Seroprevalence in the United States 2009–2010 and Comparison with the Past Two Decades
21. The association of Toxoplasma gondii infection with neurocognitive deficits in a population-based analysis
22. Change in Hepatitis A Seroprevalence among U.S. Children and Adolescents: Results from the National Health and Nutrition Examination Survey 2003–2006 and 2007–2010
23. The Relationship Between Toxoplasma Gondii Infection and Mood Disorders in the Third National Health and Nutrition Survey
24. Chlamydia trachomatis Trends in the United States Among Persons 14 to 39 Years of Age, 1999–2008
25. Seroprevalence of Hepatitis A Virus Antibodies in the U.S.: Results from the National Health and Nutrition Examination Survey
26. Varicella Seroprevalence in the U.S.: Data from the National Health and Nutrition Examination Survey, 1999–2004
27. Seroprevalence of Antibody to Mumps Virus in the US Population, 1999–2004
28. The Prevalence of Hepatitis B Virus Infection in the United States in the Era of Vaccination
29. Seroprevalence of HIV in the US Household Population Aged 18-49 Years: The National Health and Nutrition Examination Surveys, 1999-2006
30. Seroprevalence of Q Fever in the United States, 2003–2004
31. National Seroprevalence and Risk Factors for Zoonotic Toxocara spp. Infection
32. Changes in the Prevalence of Nasal Colonization withStaphylococcus aureusin the United States, 2001–2004
33. HIV Infection in the United States Household Population Aged 18-49 Years: Results From 1999-2006
34. Toxoplasma gondii and Toxocara spp. Co-infection
35. Seroprevalence of Measles Antibody in the US Population, 1999–2004
36. Toxoplasma gondii Infection in the United States, 1999–2004, Decline from the Prior Decade
37. Toxoplasma gondiiPrevalence, United States
38. Rubella Immunity Levels in the United States Population: Has the Threshold of Viral Elimination Been Reached?
39. Hepatitis C Virus Genotypes and Viral Concentrations in Participants of a General Population Survey in the United States
40. Prevalence of HIV in the US Household Population
41. Prevalence ofStaphylococcus aureusNasal Colonization in the United States, 2001–2002
42. Seroprevalence of Six Infectious Diseases Among Adults in the United States by Race/Ethnicity: Data From the Third National Health and Nutrition Examination Survey, 1988-94
43. Racial and Ethnic Differences in the Seroprevalence of 6 Infectious Diseases in the United States: Data From NHANES III, 1988–1994
44. Tetanus and Diphtheria Immunity Among Females in the United States: Are Recommendations Being Followed?
45. Tetanus and diphtheria immunity among females in the United States: Are recommendations being followed?
46. Toxoplasma gondiiInfection in the United States, 1999–2000
47. Varicella in Americans from NHANES III: Implications for control through routine immunization
48. The Relationship Between Periodontal Disease Attributes and Helicobacter pylori Infection Among Adults in the United States
49. Relationship of Adherence to Pediatric Asthma Morbidity Among Inner-City Children
50. Serologic Immunity to Diphtheria and Tetanus in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.